Clinical Trial Update: Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing adjuvanted versus non-adjuvanted A(H1N1)v influenza vaccines in HIV-infected patients completed, assessing immunogenicity and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• A(H1N1)v influenza vaccine (adjuvanted) (A(H1N1)v influenza vaccine with adjuvant)
• A(H1N1)v influenza vaccine (non-adjuvanted) (A(H1N1)v influenza vaccine without adjuvant)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED